Arca
Skip to content
Tools
Tools

ReBOSSIS

Filler, Bone Void, Calcium Compound. 510(k) K240453, from Orthorebirth Co., Ltd. (Yokohama, JP). Product code MQV, class 2.

As of Nov 22, 2026, K240453 is an FDA 510(k) held by Orthorebirth Co., Ltd., substantially equivalent on Mar 4, 2024 after 18 days, with 2 recalls tied to it in FDA's recall database.

  • Review time: 18 days
  • Recalls: 2

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

ReBOSSIS is intended for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. ReBOSSIS is indicated to be packed gently into bony voids or gaps of the skeletal system (extremities, pelvis, posterolateral spine, and intervertebral disc space).

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Recalls

Recalls FDA ties to K240453, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record
StartedRecallStatus
Mar 25, 2026Z-2132-2026, Z-2131-2026Resorbable bone void filler falls outside standard specifications.Open

Other MQV clearances

The newest 510(k)s for the same product code; their median review was 118 days; see every MQV device

Record

Type
Traditional
Received
Feb 15, 2024
Review panel
Orthopedic
Regulation
21 CFR 888.3045

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.